Legato Capital Management LLC raised its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 26.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 40,570 shares of the health services provider's stock after purchasing an additional 8,436 shares during the period. Legato Capital Management LLC owned 0.07% of Maximus worth $2,766,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of MMS. Captrust Financial Advisors acquired a new stake in shares of Maximus during the fourth quarter worth $276,000. GAMMA Investing LLC increased its holdings in shares of Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after acquiring an additional 294 shares during the period. Blue Trust Inc. increased its holdings in shares of Maximus by 32.8% in the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after acquiring an additional 303 shares during the period. Janney Montgomery Scott LLC increased its holdings in shares of Maximus by 70.5% in the 1st quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after acquiring an additional 4,196 shares during the period. Finally, Oppenheimer Asset Management Inc. increased its holdings in shares of Maximus by 24.0% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 6,461 shares of the health services provider's stock worth $441,000 after acquiring an additional 1,249 shares during the period. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is currently owned by company insiders.
Maximus Stock Up 0.9%
Shares of NYSE:MMS opened at $71.67 on Wednesday. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The firm has a market cap of $4.04 billion, a P/E ratio of 14.25 and a beta of 0.61. The company's 50-day moving average price is $71.55 and its two-hundred day moving average price is $70.75.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The business had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.56% and a return on equity of 23.37%. Maximus's revenue for the quarter was up 1.0% on a year-over-year basis. During the same period last year, the company posted $1.57 EPS. As a group, research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date is Friday, August 15th. Maximus's dividend payout ratio is currently 23.86%.
Analyst Ratings Changes
Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.
View Our Latest Stock Analysis on Maximus
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.